| Acceptance rate | 46% |
|---|---|
| Time to first decision | 6 months* |
| Time to decision with review | 50 days* |
*Approximate number of days
**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.
ACTA Pharmaceutica Sciencia
2023 , Vol 61 , Num 4
DBeQ-mediated pharmacological modulation of the retrotranslocation step of ERAD may exhibit a potent therapeutic approach against colorectal cancer
1 Department of Biochemistry, Faculty of Pharmacy, Suleyman Demirel University, 32260, Isparta, Türkiye, 2 Department of Bioengineering, Institute of Science, Suleyman Demirel University, 32260, Isparta, Türkiye
DOI :
10.23893/1307-2080.APS6125